aloxistatin has been researched along with Amyloid Deposits in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hook, G; Hook, V; Kindy, M; Toneff, T; Yu, J | 1 |
1 other study(ies) available for aloxistatin and Amyloid Deposits
| Article | Year |
|---|---|
Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Cathepsin B; Cattle; Cells, Cultured; Chromaffin Cells; Cysteine Proteinase Inhibitors; Dipeptides; Humans; Leucine; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments; Plaque, Amyloid; Pyrrolidonecarboxylic Acid | 2014 |